PDLIM5 and prostate carcinoma: Furthermore, PDLIM5 has been reported to be abnormally enriched in prostate cancer tissues, with its knockdown shown to trigger suppression of proliferative, migratory and invasive abilities of prostate cancer cells (Liu et al., 2017).